Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,317 | 8,878 | 6,703 | 7,557 | 7,716 |
| TOTAL | $10,961 | $9,686 | $7,885 | $9,076 | $9,340 |
| Non-Current Assets | |||||
| PPE Net | 70 | 78 | 77 | 99 | 127 |
| Intangibles | 11,148 | 11,148 | 11,148 | 11,148 | 11,148 |
| Other Non-Current Assets | 1,184 | 1,214 | 1,243 | 1,270 | 398 |
| TOTAL | $12,402 | $12,440 | $12,468 | $12,517 | $11,673 |
| Total Assets | $23,363 | $22,126 | $20,353 | $21,593 | $21,013 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,962 | 6,854 | 5,682 | 7,913 | 6,896 |
| TOTAL | $7,962 | $6,854 | $5,682 | $7,913 | $6,896 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 218 | 266 | 41,591 | 20,845 | 14,075 |
| TOTAL | $218 | $266 | $41,591 | $20,845 | $14,075 |
| Total Liabilities | $8,180 | $7,120 | $47,273 | $28,758 | $20,971 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,336 | 5,336 | 2,036 | 1,211 | 565 |
| Common Shares | 5 | 3 | 49 | 30 | 14 |
| Retained earnings | -218,849 | -206,004 | -221,556 | -167,443 | -159,803 |
| Other shareholders' equity | -52 | 10 | -44 | -38 | -38 |
| TOTAL | $15,183 | $15,006 | $-26,920 | $-7,165 | $42 |
| Total Liabilities And Equity | $23,363 | $22,126 | $20,353 | $21,593 | $21,013 |